Carmelo Scarpignato

Clinical investigation of gastric function

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Clinical investigation of gastric function

4,3

Advances in drug therapy of gastroesophageal reflux disease

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Advances in drug therapy of gastroesophageal reflux disease

4,3

Management of esophageal varices

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Management of esophageal varices

4,3

Functional investigation of esophageal disease

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Functional investigation of esophageal disease

4,3

NSAID-induced gastroduodenal damage

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato NSAID-induced gastroduodenal damage

4,3

Esophageal mucosal defence recent advances

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Esophageal mucosal defence recent advances

4,3

Octreotide: from basic science to clinical medicine

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Octreotide: from basic science to clinical medicine

4,3

Somatostatin in digestive diseases: improving the treatment options

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Somatostatin in digestive diseases: improving the treatment options

4,3

Clinical pharmacology and therapy of Helicobacter pylori infection

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Clinical pharmacology and therapy of Helicobacter pylori infection

4,3

Somatostatin analogs in cancer management

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Somatostatin analogs in cancer management

4,3

Rifaximin: a poorly absorbed antibiotic

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Rifaximin: a poorly absorbed antibiotic

4,3

Bacterial flora in digestive disease

Carmelo Scarpignato

Vypredaná

Carmelo Scarpignato Bacterial flora in digestive disease

4,3